Skip to content

Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures

Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures: An Evaluation of Narcotic Consumption, Pain, Wound Healing, and Patient Satisfaction

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00950183
Enrollment
36
Registered
2009-07-31
Start date
2007-02-28
Completion date
2010-12-31
Last updated
2016-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Narcotic Consumption, Pain, Wound Healing, Patient Satisfaction

Keywords

cryotherapy, postoperative pain, Iceman, primary first metatarsal osteotomy (PMO), lateral ankle ligament reconstruction (LAR)

Brief summary

This study will compares differences in pain level, narcotic consumption, wound healing, patient satisfaction in patients randomized to the Iceman® cold pack therapy system (djOrtho, Inc) versus those who use ice. This will be assessed postoperatively following the foot and ankle procedures primary first metatarsal osteotomy (PMO) or lateral ankle ligament reconstruction (LAR).

Interventions

DEVICEIceman® Cold Therapy unit (djOrtho)

postoperative cold therapy

OTHERIce

postoperative cold therapy

Sponsors

DJO Incorporated
CollaboratorINDUSTRY
OrthoCarolina Research Institute, Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients who are scheduled to have either lateral ankle ligament reconstruction (LAR) surgery or primary first metatarsal osteotomy surgery * Patients who agree to be compliant and to keep a patient diary daily for 2 weeks and to return to the clinic for a 2 week postoperative follow- up appointment

Exclusion criteria

* Patients with Diabetes Mellitus, peripheral vascular disease, Reynauds Syndrome, hypersensitivity to cold * Patients allergic to hydrocodone or oxycodone * Patients who are unwilling to complete the patient diary and/or follow their specific cold therapy instructions

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) Pain Scorespostop day 1 up to postop day 14

Secondary

MeasureTime frame
Narcotic Pain Medication Usagepostop day 1 up to postop day 14
Patient Satisfactionfirst postoperative visit (between postop day 10 and 14)
Surgical ComplicationsDay of Surgery
Postoperative Complicationspostop day 1 up to postop day 14

Countries

United States

Participant flow

Pre-assignment details

The study was terminated before patients were randomized to the treatment arms. Thus, it is not possible to report the results for the individual treatment arms.

Participants by arm

ArmCount
Foot and Ankle Surgery
Our target enrollment was 82 participants. We only enrolled 36 participants. The study was terminated due to low enrollment. As a result, patients were never randomized.
36
Total36

Baseline characteristics

CharacteristicFoot and Ankle Surgery
Age, Continuous56 Years
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 36
serious
Total, serious adverse events
0 / 36

Outcome results

Primary

Visual Analog Scale (VAS) Pain Scores

Time frame: postop day 1 up to postop day 14

Population: Data not analyzed due to study termination

Secondary

Narcotic Pain Medication Usage

Time frame: postop day 1 up to postop day 14

Population: Data not analyzed due to study termination.

Secondary

Patient Satisfaction

Time frame: first postoperative visit (between postop day 10 and 14)

Population: Data not analyzed due to study termination

Secondary

Postoperative Complications

Time frame: postop day 1 up to postop day 14

Population: Data not analyzed due to study termination

Secondary

Surgical Complications

Time frame: Day of Surgery

Population: Data not analyzed due to study termination

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026